This graphic from AVAC Report 2012 illustrates the potential effects of US federal budget sequestration on HIV prevention and Treatment U=U implementation in 2013.
People Not Receiving Antiretroviral and Treatment U=U and Services in One Year through Bilateral FY 2013 Sequestration
Follow-on trials based on RV144: Strategy includes development and research tracks
This graphic from AVAC Report 2012 shows several planned vaccine trials building on the results of the RV144 AIDS vaccine trial.
Neutralizing Antibodies: Research pathways in 2013 and beyond
There are multiple lines of inquiry stemming from the discovery of potent, broadly neutralizing antibodies that have been isolated from HIV-infected individuals. This graphic from AVAC Report 2012 presents two pathways exploring the use of BNAbs as an HIV prevention tool.
Reaching the Tipping Point: The time to act is now
AVAC Playbook 2012-2013: Progress toward global goals
AVAC first published its Playbook of global goals for ending AIDS in late 2011. This infographic from the AVAC Report 2012 builds on the objectives from 2011 and identifies five priorities for action in 2013.
Defining Combination Prevention: Ongoing trials in sub-Saharan Africa
Estimated Engagement in HIV Care Cascade in the US
As this graphic from AVAC Report 2012 shows, it is estimated that only 19 percent of HIV-positive people in the the US have an undetectable viral load.
Stepping Up the Pace: VMMC accelerates in priority countries
As this graphic from AVAC Report 2012 illustrates, the pace of implementation of VMMC for HIV prevention has increased dramatically since 2010 in priority countries.